Literature DB >> 10403679

A high throughput assay of the hepatitis C virus nonstructural protein 3 serine proteinase.

N Kakiuchi1, S Nishikawa, M Hattori, K Shimotohno.   

Abstract

A simple assay was developed based on intramolecular fluorescence resonance energy transfer for detection of the activity of hepatitis C virus (HCV) serine proteinase. Two quenched-fluorogenic substrates, (7-methoxycoumarin-4-yl)acetyl (Mca) Asp-Asp-Ile-Val-Pro-Cys-Ser-Met-Ser-(2,4-dinitrophenyl, Dnp) Lys (Mca-Asp-Asp-Ile-Val-Pro-Cys-Ser-Met-Ser-Lys[Dnp], QF-1) and Mca-Asp-Asp-Ile-Val-Pro-Cys-Ser-Met-Lys(Dnp)-Arg-Arg (QF-2), which derived from the NS5A/5B junction of the HCV polyprotein, were designed. Kinetic studies revealed that QF-1 and QF-2 had high affinity for a recombinant enzyme which is a fusion protein of maltose binding protein and almost entire nonstructural protein (MBP-NS3), with Km values comparable to that of longer substrate based on the same cleavage site. QF-1 and QF-2 were cleaved by MBP-NS3 efficiently with kcat values of 7.5 and 4.2 min(-1), respectively. QF-2 was also found to be a good substrate of deltaNS3 which contained serine proteinase part of NS3 with kcat value of 4.3 min(-1). The cleavage reaction is detected continuously by the elevation of the fluorescence due to release from quenching. The fluorescence of the substrates increases in proportion to progress of the cleavage reaction under the standard conditions. This method was applied for screening of HCV serine protease inhibitors using a fluorescence multiwell plate reader. A group of natural occurring products, flavonoids, was subjected to be screened. Two flavonoids out of 25 were found to inhibit the enzyme moderately at a concentration of 100 microM. The data agreed with those obtained by high-performance liquid chromatography (HPLC). This method is suited to sensitive quantitation of the enzyme reaction as well as the high throughput analysis of the inhibitors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403679     DOI: 10.1016/s0166-0934(99)00034-8

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  6 in total

1.  Development of a cell-based high-throughput specificity screen using a hepatitis C virus-bovine viral diarrhea virus dual replicon assay.

Authors:  Donald R O'Boyle; Peter T Nower; Julie A Lemm; Lourdes Valera; Jin-Hua Sun; Karen Rigat; Richard Colonno; Min Gao
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

2.  Establishment of a simple assay in vitro for hepatitis C virus NS3 serine protease based on recombinant substrate and single-chain protease.

Authors:  Gui-Xin Du; Li-Hua Hou; Rong-Bin Guan; Yi-Gang Tong; Hai-Tao Wang
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

3.  Development of a cell-based hepatitis C virus infection fluorescent resonance energy transfer assay for high-throughput antiviral compound screening.

Authors:  Xuemei Yu; Bruno Sainz; Susan L Uprichard
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

4.  Discovery and characterization of substituted diphenyl heterocyclic compounds as potent and selective inhibitors of hepatitis C virus replication.

Authors:  Peiyong Huang; Dane A Goff; Qi Huang; Anthony Martinez; Xiang Xu; Scott Crowder; Sarkiz D Issakani; Emily Anderson; Ning Sheng; Philip Achacoso; Ann Yen; Todd Kinsella; Ihab S Darwish; Rao Kolluri; Hui Hong; Kunbin Qu; Emily Stauffer; Eileen Goldstein; Rajinder Singh; Donald G Payan; H Henry Lu
Journal:  Antimicrob Agents Chemother       Date:  2008-01-28       Impact factor: 5.191

5.  Cell-based hepatitis C virus infection fluorescence resonance energy transfer (FRET) assay for antiviral compound screening.

Authors:  Xuemei Yu; Susan L Uprichard
Journal:  Curr Protoc Microbiol       Date:  2010-08

6.  Simultaneous assay for protease activities of hepatitis C virus and human immunodeficiency virus based on fluorescence detection.

Authors:  Tsutomu Kabashima; Keiko Tonooka; Makoto Takada; Masaaki Kai; Takayuki Shibata
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.